Effectiveness of Curcumin-based Food Supplement in Reducing Pain and Inflammatory Component in Osteoarthritis
Launched by KOS CARE SRL - ISTITUTO DI RIABILITAZIONE SANTO STEFANO · Dec 18, 2019
Trial Information
Current as of July 04, 2025
Unknown status
Keywords
ClinConnect Summary
INTRODUCTION Gonarthrosis is the most common disorder of the musculoskeletal system, with an age-related prevalence varying between 12-55%. The treatment of OA is mostly symptomatic and includes the use of analgesics, NSAIDs, exercise and even surgery. However, the use of long-term NSAIDs is associated with potentially serious side effects, with a high risk of hospitalization and death. As a result, the use of alternative and complementary therapies (CAM), such as nutritional therapies in patients with OA, is extremely frequent.
The objective of this study will be to evaluate the effective...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Presence of osteoarthritis of the knee. Traditional American College of Rheumatology criteria, which are based on the presence of pain (gonalgia) plus at least three of the following characteristics, will be used for the diagnosis of osteoarthritis of the knee:
- • Age \> 50 years
- • Stiffness in the morning \< 30 minutes
- • Presence of articular rusting
- • Painfulness of the bones
- • Tumefaction of the bones
- • Absence of palpable heat
- Exclusion Criteria:
- • - pregnancy and breastfeeding (if the potential participant does not declare to be in a menopausal state)
- • other specific contraindications/intolerances to the compounds contained in the supplement (e.g. celiac disease, allergy)
- • simultaneous intake of other supplements
- • to be at the time of enrolment for treatment with anti-inflammatory or pain-relieving treatment for other clinical conditions
- • Participation in other clinical studies
- • State of inability to understand or desire
About Kos Care Srl Istituto Di Riabilitazione Santo Stefano
Kos Care Srl - Istituto di Riabilitazione Santo Stefano is a leading clinical trial sponsor dedicated to advancing rehabilitation healthcare through innovative research and evidence-based practices. With a focus on enhancing patient outcomes, the institution specializes in multidisciplinary rehabilitation programs that integrate cutting-edge therapies and technologies. Committed to ethical standards and regulatory compliance, Kos Care Srl actively collaborates with healthcare professionals and academic institutions to conduct high-quality clinical trials aimed at improving therapeutic interventions and quality of life for individuals with diverse rehabilitation needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Massimo Frascarello, MD
Principal Investigator
Istituto Santo Stefano
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials